Ligand profile
GAX
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_04673 — phenylalanyl-tRNA synthetase alpha subunit
Identifiers
Database identifiers and provenance.
- Ligand ID
GAX- PDB
2rhq- UniProt (similar protein)
Q4L5E3- Target protein
- KP13_04673
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 107.5
- −1 ≤ LogP ≤ 5 2.69
- MW ≤ 500 Da 444.5
- LogP ≤ 5 2.69
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 107.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccnc(c1)N2CCN(CC2)S(=O)(=O)c3cccc(c3)NC(=O)Nc4nccs4c1ccnc(c1)N2CCN(CC2)S(=O)(=O)c3cccc(c3)NC(=O)Nc4nccs4
InChI=1S/C19H20N6O3S2/c26-18(23-19-21-8-13-29-19)22-15-4-3-5-16(14-15)30(27,28)25-11-9-24(10-12-25)17-6-1-2-7-20-17/h1-8,13-14H,9-12H2,(H2,21,22,23,26)InChI=1S/C19H20N6O3S2/c26-18(23-19-21-8-13-29-19)22-15-4-3-5-16(14-15)30(27,28)25-11-9-24(10-12-25)17-6-1-2-7-20-17/h1-8,13-14H,9-12H2,(H2,21,22,23,26)
NJPVZSIGDRLLTD-UHFFFAOYSA-NNJPVZSIGDRLLTD-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01409
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand GAX →
- PDB RCSB structure 2rhq →
- UniProt UniProt Q4L5E3 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “GAX”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04673.
PDB 7
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).